Thursday, July 16, 2009

A number of meds and indeed diseases, can induce sudden or delayed, neuropsychiatric symptoms. Fluoroquinolones antibiotics, Lariam/Mefloquine, beta blockers, Anti depressants, analgesics, anesthetics (both general and local) and many more.

Conditions such as hypothyroidism, Huntington's Disease, Lyme Disease, infectious pathogens, mercury and other heavy metals accumulation, changes in hormones, etc.. are also known to cause neuropsychiatric symptoms.

Below is an article, alerting about asthma drug suspected of causing neuropsychiatric symptoms in children. I suspect this is also happening to adults. Nasacort for sinusitis and rhinitis, can also cause neuropsychiatric symptoms.

If your or a member or family suddenly or over a period of time, display psychiatric symptoms, please, investigate.

Often, there is an underlying cause as mentioned above. Avoid psychiatric drugs, see vids posted below.

Asthma Drug linked to suicide attempts, thoughts of self-harm

OTTAWA — The side-effects of a popular asthma medication that has been sold in Canada for 12 years has been linked to suicide attempts and thoughts of suicide, as well as feelings of depression and hostility.

The July 2009 issue of the Canadian Adverse Reaction Newsletter from Health Canada cites montelukast sodium — which has been marketed in Canada since 1997 as Singulair — as having several connections to the alarming reactions.

Between its introduction to the Canadian market and Jan. 31, 2009, Singulair has been linked to two suicide attempts in Canada and 11 cases where users had thoughts of suicide or self-harm. In 29 other cases, 14 of which were labelled as "serious adverse reactions," those affected suffered from depression, hostility or other psychosis. No deaths have been linked to the drug's side-effects.

Karen Liberman, executive director of the Mood Disorders Association of Ontario, said the side-effects are disturbing, given how common asthma is.

"It's kind of like a perfect storm," Liberman said. "Asthma is so prevalent, and depression and bipolar (disorder) and anxiety are more prevalent.

"One of the things we know about these illnesses is they are susceptible to stress on the body, whether it's chronic pain, life stress or relationship stress. If you carry the genetic vulnerability to depression, these are the things that can trigger it. As you can imagine, if you are someone with a chronic disease like asthma, and you take medication that's supposed to help, and it precipitates something like depression, that would be very troubling."

Between September 2007 and July 2008, the list of adverse reactions stemming from the drug was amended in Canada, which warns patients that "if suicidal thoughts and actions occur, montelukast should be discontinued and a physician or pharmacist contacted immediately."

In eight reported cases, thoughts of suicide or self-harm subsided once the dose was reduced or stopped completely, while the same adverse reaction returned in one case when the dose was restarted.

In the 29 less severe cases, the reactions were eliminated by lowering the dose or stopping use of the drug in 19 of those cases. Upon reintroduction, the symptoms returned in four cases.

More than half of the reported cases — 26 of 42 — were in people under the age of 18.

The drug is used to treat asthma in people older than age two, as well as patients age 15 and older who suffer from severe seasonal allergies. Cont...http://www.leaderpost.com/news/Asthma+drug+linked+suicide+attempts+thoughts+self+harm/1768232/story.html

Popular Asthma Medicine Singulair Associated With Psychiatric Disorders In Children

New Medical Journal Article Follows June 2009 FDA-Required Warning For Singulair About Neuropsychiatric Events

(Posted by Tom Lamb at DrugInjuryWatch.com)

On June 12, 2009 the FDA announced a new warning about an increased risk of neuropsychiatric events for the asthma medicine Singulair (montelukast)-- as well as some other less popular leukotriene inhibitors, Accolate (zafirlukast) as well as Zyflo and Zyflo CR (zileuton).

http://www.drug-injury.com/druginjurycom/drug_safety_alerts/

No comments:

Post a Comment

List of some Fluoroquinolones Antibiotics

List of some fluoroquinolones antibiotics- for list of symptoms go to: www.fluoroquinolones.org
forum: www.favc.info


Generic & Brand Name of most common Fluoroquinolones

Brand Name: Trovan - Zithromax
Generic Name: Trovafloxacin and Azithromycin

Brand Name: Factive
Generic Name: Gemifloxacin Mesylate

Brand Name: Zagam
Generic Name: Sparfloxacin

Brand Name: Vigamox
Generic Name: Moxifloxacin

Brand Name: Vigamox
Generic Name: Moxifloxacin

Brand Name: Cinobac
Generic Name: Cinoxacin

Brand Name: Penetrex
Generic Name: Enoxacin

Brand Name: Tequin
Generic Name: Gatifloxacin (Removed from US Market - May 2006)

Brand Name: Levaquin
Generic Name: Levofloxacin

Brand Name: Floxin
Generic Name: Ofloxacin

Brand Name: Synercid
Generic Name: Quinupristin and Dalfopristin

Brand Name: Trovan - Zithromax

Brand Name: Zymar
Generic Name: Gatifloxacin Ophthalmic Solution

Brand Name: Avelox
Generic Name: Moxifloxacin HCL

Brand Name: Floxin Otic Singles

Brand Name: Ciprodex
Generic Name: Ciprofloxacin and Dexamethasone

Brand Name: Raxar
Generic Name: Grepafloxacin

Brand Name: Ocuflox
Generic Name: Ofloxacin Ophthalmic

Brand Name: Quixin
Generic Name: Levofloxacin

Brand Name: Cipro
Generic Name: Ciprofloxacin

Brand Name: Proquin XR
Generic Name: Ciprofloxacin Hcl

Brand Name: Requip XL
Generic Name: Ropinirole Extended Release Tablets

Brand Name: Zanaflex
Generic Name: Tizanidine

Brand Name: Noroxin
Generic Name: Norfloxacin

Brand Name: Maxaquin
Generic Name: Lomefloxacin Hcl

Brand Name: Ciloxan Ophthalmic Solution
Generic Name: Ciprofloxacin HCL Ophthalmic Solution

Brand Name: Cipro XR
Generic Name: Ciprofloxacin Extended-Release

Generic Name Norloaxin Brand Name: Noroxin

Generic Name Temafloxacin Brand name Omniflox